The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks’ gestation

Overview of attention for article published in BMC Pediatrics, June 2016

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 1 X post from an account with 1,861 followers.

BMC Pediatr. 2016 Jun 1;16(1):72. The N3RO trial: a randomised controlled trial of docosahexaenoic acid to... https://t.co/dEGRqYEDGU

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.